Literature DB >> 19083000

Cancer and the tumor microenvironment: a review of an essential relationship.

Flaubert Mbeunkui1, Donald J Johann.   

Abstract

PURPOSE: The role of the microenvironment during the initiation and progression of carcinogenesis is now realized to be of critical importance, both for enhanced understanding of fundamental cancer biology, as well as exploiting this source of relatively new knowledge for improved molecular diagnostics and therapeutics.
METHODS: This review focuses on: (1) the approaches of preparing and analyzing secreted proteins, (2) the contribution of tumor microenvironment elements in cancer, and (3) the potential molecular targets for cancer therapy.
RESULTS: The microenvironment of a tumor is an integral part of its physiology, structure, and function. It is an essential aspect of the tumor proper, since it supplies a nurturing environment for the malignant process. A fundamental deranged relationship between tumor and stromal cells is essential for tumor cell growth, progression, and development of life threatening metastasis. Improved understanding of this interaction may provide new and valuable clinical targets for cancer management, as well as risk assessment and prevention. Non-malignant cells and secreted proteins from tumor and stromal cells are active participants in cancer progression.
CONCLUSIONS: Monitoring the change in the tumor microenvironment via molecular and cellular profiles as tumor progresses would be vital for identifying cell or protein targets for cancer prevention and therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19083000      PMCID: PMC2858592          DOI: 10.1007/s00280-008-0881-9

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  99 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts.

Authors:  J E Park; M C Lenter; R N Zimmermann; P Garin-Chesa; L J Old; W J Rettig
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

3.  Targeted inhibition of osteopontin expression in the mammary gland causes abnormal morphogenesis and lactation deficiency.

Authors:  M Nemir; D Bhattacharyya; X Li; K Singh; A B Mukherjee; B B Mukherjee
Journal:  J Biol Chem       Date:  2000-01-14       Impact factor: 5.157

4.  Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs.

Authors:  L A García-Rodríguez; C Huerta-Alvarez
Journal:  Epidemiology       Date:  2001-01       Impact factor: 4.822

5.  Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3.

Authors:  J C Gutheil; T N Campbell; P R Pierce; J D Watkins; W D Huse; D J Bodkin; D A Cheresh
Journal:  Clin Cancer Res       Date:  2000-08       Impact factor: 12.531

Review 6.  Infections as a major preventable cause of human cancer.

Authors:  H Kuper; H O Adami; D Trichopoulos
Journal:  J Intern Med       Date:  2000-09       Impact factor: 8.989

Review 7.  Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer.

Authors:  Y Li; W P Hively; H E Varmus
Journal:  Oncogene       Date:  2000-02-21       Impact factor: 9.867

8.  High levels of TIMP-2 correlate with adverse prognosis in breast cancer.

Authors:  A Remacle; K McCarthy; A Noël; T Maguire; E McDermott; N O'Higgins; J M Foidart; M J Duffy
Journal:  Int J Cancer       Date:  2000-03-20       Impact factor: 7.396

9.  Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties.

Authors:  P Matarrese; O Fusco; N Tinari; C Natoli; F T Liu; M L Semeraro; W Malorni; S Iacobelli
Journal:  Int J Cancer       Date:  2000-02-15       Impact factor: 7.396

10.  Osteopontin-induced, integrin-dependent migration of human mammary epithelial cells involves activation of the hepatocyte growth factor receptor (Met).

Authors:  A B Tuck; B E Elliott; C Hota; E Tremblay; A F Chambers
Journal:  J Cell Biochem       Date:  2000-06-06       Impact factor: 4.429

View more
  163 in total

1.  Immobilizing reporters for molecular imaging of the extracellular microenvironment in living animals.

Authors:  Zuyong Xia; Yun Xing; Jongho Jeon; Young-Pil Kim; Jessica Gall; Anca Dragulescu-Andrasi; Sanjiv S Gambhir; Jianghong Rao
Journal:  ACS Chem Biol       Date:  2011-08-23       Impact factor: 5.100

Review 2.  Autophagy and cancer cell metabolism.

Authors:  Fred Lozy; Vassiliki Karantza
Journal:  Semin Cell Dev Biol       Date:  2012-01-18       Impact factor: 7.727

3.  Interventional therapy of head and neck cancer with lipid nanoparticle-carried rhenium 186 radionuclide.

Authors:  J Tyler French; Beth Goins; Marcela Saenz; Shihong Li; Xavier Garcia-Rojas; William T Phillips; Randal A Otto; Ande Bao
Journal:  J Vasc Interv Radiol       Date:  2010-05-15       Impact factor: 3.464

4.  Peripheral blood neutrophil count as a prognostic factor for patients with hepatocellular carcinoma treated with sorafenib.

Authors:  Jia Yuan; Hongming Liang; Jinghuan Li; Miao Li; Bei Tang; Hui Ma; Xiaoying Xie; Xin Yin; Lan Zhang; Zhenggang Ren
Journal:  Mol Clin Oncol       Date:  2017-09-19

Review 5.  Aiming to immune elimination of ovarian cancer stem cells.

Authors:  Jiabo Di; Tjitske Duiveman-de Boer; Carl G Figdor; Ruurd Torensma
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

6.  Perspective: Flicking with flow: Can microfluidics revolutionize the cancer research?

Authors:  Tamal Das; Suman Chakraborty
Journal:  Biomicrofluidics       Date:  2013-01-31       Impact factor: 2.800

Review 7.  Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.

Authors:  Yunlu Dai; Can Xu; Xiaolian Sun; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2017-05-18       Impact factor: 54.564

Review 8.  Phytochemicals: Current strategies for treating breast cancer.

Authors:  Bridg'ette B Israel; Syreeta L Tilghman; Kitani Parker-Lemieux; Florastina Payton-Stewart
Journal:  Oncol Lett       Date:  2018-03-20       Impact factor: 2.967

9.  Human uterine leiomyoma-derived fibroblasts stimulate uterine leiomyoma cell proliferation and collagen type I production, and activate RTKs and TGF beta receptor signaling in coculture.

Authors:  Alicia B Moore; Linda Yu; Carol D Swartz; Xaiolin Zheng; Lu Wang; Lysandra Castro; Grace E Kissling; David K Walmer; Stanley J Robboy; Darlene Dixon
Journal:  Cell Commun Signal       Date:  2010-06-10       Impact factor: 5.712

10.  The tumor microenvironment: the making of a paradigm.

Authors:  Isaac P Witz
Journal:  Cancer Microenviron       Date:  2009-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.